GVR Report cover ASEAN Poultry Vaccines Market Size, Share & Trends Report

ASEAN Poultry Vaccines Market Size, Share & Trends Analysis Report By Product (Attenuated Live Vaccines, Inactivated Vaccines, DNA Vaccines), By Application, By Disease, By Country, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68040-007-0
  • Number of Pages: 150
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Report Overview

The ASEAN poultry vaccines market size was valued at USD 118.73 million in 2022 and is expected to expand at a compund annual growth rate (CAGR) of 8.90% from 2023 to 2030. The market is primarily driven by the growing population, rapid urbanization, increasing prevalence of poultry diseases, rising government initiatives, and reducing antibiotic usage. In recent years, the prevalence of infections caused by antibiotic-resistant salmonella species has increased in the poultry population of ASEAN countries, such as Malaysia, Myanmar, and Singapore, according to a study published by MDPI in July 2022. Thus, the industry’s focus has now shifted toward other feasible options, such as vaccinations.

ASEAN poultry vaccines market size, by product, 2020 - 2030 (USD Million)

Southeast Asian countries such as Cambodia, Indonesia, Thailand, and Vietnam are witnessing rapid urbanization and a growing population. The U.S. Bureau of Census data suggests that the ASEAN region’s (inclusive of 10 countries) total population grew by 11.6% in 2017 from 2008 and is expected to reach 720.0 million by 2027. In addition, according to Bloomberg, the urban population in the ASEAN region will grow by 100million people by 2030. The region’s per capita GDP has grown annually by 3.4% in the last decade and is expected to grow by 3.5% in the next decade.

As the region’s population, urbanization, and income are increasing, meat consumption is also widely growing. This region has witnessed several advancements in poultry production in the past decade. For instance, the U.S. Department of Agriculture reported that Southeast Asia’s poultry production has grown by 56.0% in the previous decade, reaching 9.2 Million Metric Tons (MMT) in 2018, and is expected to reach 12.3 MMT by 2028.

Vietnam’s poultry and hog sectors have grown the fastest compared to other ASEAN regions, and Indonesia is projected to continue being the largest egg producer in the coming decade. In addition, Thailand is considered to be the largest exporter of poultry products. Therefore, increasing poultry production in ASEAN countries and growing poultry meat consumption are driving the market growth.

Poultry farmers face numerous challenges such as maintaining poultry health, immunity, and stable production. In addition, the rising concerns about  food safety, reduction in consumer confidence, product safety & quality issues, and most importantly the re-emergence and new emergence of infectious diseases are continuously challenging ASEAN poultry production units. The recent food borne or zoonotic disease outbreaks, such as COVID-19, avian influenza, and salmonellosis, have raised contagious issues among animal products globally, which reduced meat consumption rates. Due to the reduced demand and production during the pandemic, several poultry farms faced closure owing to cash flow problems.

Furthermore, players in the poultry industry, particularly commercial farms, have been working to improve closed-house implementation to maximize production and efficiency. By the end of 2021, practically all company-owned farms, including the majority of farmer partners, were expected to be moved to the closed-house approach. In the poultry industry, the increased synergy of companies, integration between upstream and downstream business divisions, and increasing initiatives from public & private market players are expected to fuel the market growth during the forecast period.

Product Insights

The attenuated live vaccines segment dominated the market and accounted for the largest revenue share in 2022. Attenuated live vaccines are either formulated from cell cultures of wild-type viruses or made by utilizing live organisms from non-target hosts. They are prepared by reducing the virulent strain’s toxicity via chemical, physical, and genetic modifications. This way, the strain loses its pathogenicity but retains its immunogenicity. These vaccines help stimulate active and passive immunities in chickens. The vaccination is administered intramuscularly in animals, resulting in a reduced risk of death due to diseases. Attenuated vaccines should be administered only to animals that have been tested for the vaccine or their usage has been approved in the animals.

The DNA vaccine segment is estimated to witness the fastest growth rate during the forecast period. DNA vaccines are a type of subunit vaccine with no risk of infection or reversion to virulence, they have been suggested as potential treatments for poultry diseases. DNA vaccines are inexpensive to produce & store, easy to design, and can be used for simultaneous immunizations against several infections. In many animal studies, the administration of DNA vaccines has been proven to elicit immune responses and offer a defense against threats.

The application of DNA vaccines in the chicken industry is hampered by drawbacks such as the difficulty to elicit robust immunity and the fact that they are not currently appropriate for mass immunization. The existing delivery restrictions of DNA vaccines for veterinary applications have been addressed, and the introduction of either biological or physical carriers has been suggested as a potential remedy.

Application Insights

The breeder segment dominated the market and accounted for the largest revenue share in 2022.Breeders are those who produce both layers (eggs) and broilers (meat). Many different people breed poultry for a variety of reasons and objectives. Commercial breeding, village/backyard breeding, and fancy/exhibition breeding are the three primary subcategories of poultry breeding. Hatcheries supply both the broiler and layer industries, and breeding for the commercial poultry business is done on a massive industrial scale. 

According to the Thai Broiler Processing Exporters Association, the Thai poultry market features more than 40 players. Only 20% of these market participants are integrated commercial farms or large to medium commercial farms. With 29.0% of global production, Charoen Pokphand Foods Thailand is the largest company by production volume. Laemthong, Bet agro, Thai Foods Group, Saha Farm, and GFPT are the companies that come after it.

ASEAN poultry vaccine market share, by application, 2022 (%)

The layer segment is estimated to witness the fastest growth rate during r the forecast period. Raising egg-laying chickens for commercial egg production is known as layer poultry farming. A special breed of a hen, named the layer, needs to be cared for from day one. They start producing eggs for the marketplace when they are 18 to 19 weeks old. They continue to lay eggs until they are about 72 and 78 weeks old. They might consume about 2.25 kg of feed during their egg-laying cycle and lay about 1.0 kg of eggs. The outbreak of COVID-19 in Myanmar and the subsequent response severely impacted both broiler and layer farms. Prices for eggs have increased for the consumers as a result of layer farms' poor response to the rise in egg demand after the initial COVID-19 waves.

Disease Type Insights

The salmonella segment dominated the market and accounted for the largest revenue share in 2022. The prevalence of Salmonella spp. in developed economies as compared to developing ones is lower in chicken and poultry products. Overall Salmonella spp. infection incidence is on the rise. Additionally, the review noted the existence of multidrug-resistant salmonella strains in several Asian countries. Treating, preventing, and engaging in campaigns to control the infections typically bear a significant cost, and therefore, the rising number of infectious diseases linked to Salmonella has become a burden for most developing economies. Additionally, researchers and the general public are more aware of the wide range of Salmonella serovars and the high frequency of shifting trends in salmonellosis as a result of the emergence of novel serotypes and antibiotic resistance.

Avian Influenza (AI) affects farmed poultry, as well as pet, and wild birds. A few AI viruses are highly pathogenic, producing severe systemic disease with multiple organ failure and significant mortality, while most AI viruses in domestic poultry are of moderate pathogenicity causing subclinical infections, respiratory sickness, or decreases in egg production. In agar gel immunodiffusion assays, serology can identify avian influenza viruses of type A orthomyxo viruses, often known as Influenza virus A or Alpha influenza virus. They are distinguished by antigenically similar nucleoprotein and matrix internal proteins. There are 16 hemagglutinin (H1-16) and 9 neuraminidase (N1-9) subtypes of AI viruses.

Country Insights

Indonesia accounted for the maximum revenue share of more than 19.0% in 2022, owing to the increasing chicken meat consumption and poultry production rates in the country, which further boosts demand for the import of technology for poultry keeping, feeding, & storage. Between 2010 and 2019, Indonesian chicken consumption increased from 3.5 to 6 Kg per person per year, and this trend is expected to continue. Approximately 90.0% of the country's population is Muslim and religiously forbidden from consuming pork, owing to which, poultry is a primary source of animal protein. Furthermore, cattle, goats, and mutton, as well as dairy goods, have been imported in large amounts, making them too expensive for many residents.

The rising prevalence of poultry disorders, increasing poultry production, and growing poultry product exports are the major factors expected to drive the market in Thailand. For instance, according to the USDA Foreign Agriculture Services’ published article, Thai broiler meat production was expected to reach 3.23 Million Metric Tons (MMT) in 2020, a 6.0% increase over 2019 due to increased export and domestic demand. Meanwhile, domestic chicken meat consumption (chicken meat and other broiler meat) was estimated to increase by 3.0% in 2020. Exports of chicken meat were estimated to rise another 7.0% to 1.02 MMT in 2020, in anticipation of continued growth in exports to Japan and other non-EU markets such as South Korea, China, & the Association of Southeast Asian Nations.

Key Companies & Market Share Insights

The market is highly competitive and marked by the existence of several small- and large-scale manufacturers. These players are constantly involved in strategic initiatives, such as new product launches, regional expansions, joint ventures, mergers, and acquisitions, to gain deeper market penetration. For instance, in October 2022, Zoetis expanded its poultry vaccine portfolio with the introduction of Poulvac Procerta HVT-IBD-ND. This recombinant vector vaccine is intended to protect against three diseases with one dose. Moreover, in April 2022, Elanco, in collaboration with Ginkgo Bioworks, launched a new animal healthcare company called BiomEdit. These initiatives are enhancing company’s production capacity. Some of the prominent players in  ASEAN poultry vaccine market include:

  • Boehringer Ingelheim International GmbH

  • Ceva


  • Zoetis

  • Phibro Animal Health Corporation

  • Elanco

  • Merck & Co., Inc.

  • Medion Farma

  • Malaysian Vaccines & Pharmaceuticals Sdn Bhd.

  • Kemin Industries, Inc

ASEAN Poultry Vaccine Market Report Scope

Report Attribute


Market size value in 2023

USD 128.93 million

Revenue forecast in 2030

USD 234.25 million

Growth rate

CAGR of 8.90% from 2023 to 2030

Base year for estimation


Actual estimates/Historical data

2018 - 2021

Forecast period

2023 - 2030

Quantitative units

Revenue in USD million, CAGR from 2023 to 2030

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, trends

Segments covered

Product, application, disease type

Country Scope

Thailand; Vietnam; Cambodia; Indonesia; Laos; Malaysia; Philippines; Myanmar

Key companies profiled

Boehringer Ingelheim International GmbH;Ceva; HIPRA; Zoetis; Phibro Animal Health Corporation; Elanco; Merck & Co., Inc.; Medion Farma; Malaysian Vaccines & Pharmaceuticals Sdn Bhd.; Kemin Industries, Inc.

Customization scope

Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


ASEAN Poultry Vaccines Market Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the ASEAN poultry vaccine market report based on the product, application, disease type and country:

ASEAN Poultry Vaccines Market Segmentation

  • Product Outlook (Revenue, USD Million, 2018 - 2030)

    • Attenuated Live Vaccines

    • Inactivated Vaccines

    • Subunit Vaccines

    • DNA Vaccines

    • Recombinant Vaccines

  • Application Outlook (Revenue, USD Million, 2018 - 2030)

    • Broiler

    • Layer

    • Breeder

  • Disease Type Outlook (Revenue, USD Million, 2018 - 2030)

    • Infectious Bronchitis

    • Infectious Bursal Diseases

    • Infectious Laryngotracheitis

    • Egg Drop Syndrome

    • Adenovirus

    • Duck Viral Enteritis

    • Inclusion Body Hepatitis

    • Coccidiosis

    • Avian Influenza

    • Marek's Disease

    • Newcastle Disease

    • Salmonella

    • Avian Encephalomyelitis

    • Fowl Cholera

    • Others

  • Country Outlook (Revenue, USD Million, 2018 - 2030)

    • Thailand

    • Vietnam

    • Cambodia

    • Indonesia

    • Laos

    • Malaysia

    • Philippines

    • Myanmar

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.